US 12071438
Crystal forms of an ALK2 inhibitor
granted A61PA61P19/02A61P19/08
Quick answer
US patent 12071438 (Crystal forms of an ALK2 inhibitor) held by Keros Therapeutics, Inc. expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Keros Therapeutics, Inc.
- Grant date
- Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P19/02, A61P19/08, A61P35/00, A61P35/04